NeuroSense Therapeutics Ltd. Equity
NeuroSense Therapeutics Ltd. (NRSN) had Equity of -$1.87 million as of 2023-12-31, per its 20-F filed 2024-04-04.
Discontinued › Notes
ifrs-full:Equity · last filed 2024-04-04
- 2023-12-31: Equity -$1.87M.
- 2023-06-30: Equity -$1.54M.
- 2022-12-31: Equity $5.62M.
- 2022-06-30: Equity $9.84M.
| Period end | Equity |
|---|---|
| 2023-12-31 | -$1.87M 20-F · filed 2024-04-04 |
| 2023-06-30 | -$1.54M 6-K · filed 2023-08-16 |
| 2022-12-31 | $5.62M 20-F · filed 2024-04-04 |
| 2022-06-30 | $9.84M 6-K · filed 2023-08-16 |
| 2021-12-31 | $9.01M 20-F · filed 2024-04-04 |
| 2021-06-30 | $937.00K 6-K/A · filed 2023-01-19 |
| 2020-12-31 | $659.00K 20-F · filed 2024-04-04 |
| 2019-12-31 | $918.00K 20-F · filed 2023-03-22 |
| 2018-12-31 | $109.00K 20-F · filed 2022-04-14 |